Introduction
Pinaverium bromide, a quaternary ammonium compound, has been recommended for the treatment of hypermotility disorders of the intestine, especially irritable bowel syndrome (for review see Christen, 1990) . Earlier studies on smooth muscle tissue suggest that pinaverium exerts its spasmolytic action mainly by blocking voltage-dependent Ca2+ channels and has little effect on receptor-operated channels and intracellular Ca2+ stores (Droogmans et al., 1983; Baumgartner et al., 1985; Beech et al., 1990) . Its selectivity for the intestinal tract is attributable to its low absorption by the gut and its marked hepatobiliary excretion (Jacquot et al., 1989) .
In this paper, we have characterized the interaction of pinaverium bromide with specific binding sites for L-type channel blockers (Godfraind et al., 1986) . We carried out competition experiments on homogenates of longitudinal smooth muscle from rat ileum and on dissociated 'intact' cells obtained after treatment with collagenase; we have also investigated the influence of collagenase on binding parameters. The results show that pinaverium bromide interacts with dihydropyridine binding in an apparently competitive manner at concentrations reported to be active on Ca2 + channel currents. Analysis of this interaction suggests that pinaverium bromide, a positively charged drug, has access to the dihydropyridine binding site from the outside of the cell.
Methods
Single cell preparations Single smooth muscle cells from rat ileum were prepared by the method of Momose & Gomi (1978) modified by Takayanagi et al. (1986) . Wistar rats (250-350g) were killed by I Author for correspondence. decapitation and the ileum was quickly removed. The longitudinal muscle layers were peeled manually from the underlying circular muscle and incubated at 370C for 90min in a medium (mM: NaCl 137, KCI 2.7, MgCl2 1.0, CaCl2 0.18, glucose 5.6, HEPES 4.2; pH 7.4) bubbled with a gas mixture Of 95% 02: 5% CO2. Tissue pieces were then incubated in a medium containing 0.1% purified collagenase (Sigma Ia) and 1% bovine serum albumin at 370C for 30min. The incubation was terminated by washing tissue fragments twice by centrifugation (500g for 30s). Pellets were resuspended in the incubation medium at 37°C and single cells could then be separated by gently pipetting the suspension through a wide-bore Pasteur pipette. The suspension of single cells was filtered through a nylon mesh (0.18 mm).
Membrane preparation
Freshly prepared tissue or single cells were suspended in about 10 volumes of an ice-cold solution containing 0.25 mm sucrose, 0.1 mM phenylmethylsulphonylfluoride and 5 mM Tris-HCI (pH 7.4), and homogenized with three strokes of the pestle rotating at 1500 rev min-1 in an all-glass PotterElvehjem-type grinder (Braun, Melsungen, Germany) kept at 2°C. Protein concentration was estimated according to Lowry et al. (1951) .
In some experiments, tissue homogenates were treated by collagenase in the same way as were the muscle strips used for cell isolation. The incubation was then terminated by centrifugation at 200000 g for 30 min and the pellet was resuspended with a Dounce homogenizer in ice-cold 0.25 mm sucrose buffered at pH 7.4 with 5 mM Tris-HCl.
Binding studies
The specific binding of [3H]-(+)-isradipine was measured, as described previously (Wibo et al., 1988) , by incubating frac-(D Macmillan Press Ltd, 1992 tions with the radioligand for 60 min at 370C in 2.5 ml of a buffered salt solution of the following composition (mM): NaCl 145, KCl 5, MgCl2 1.25, CaCl2 2.5, Tris 20; pH 7.4 at 370C. Non-specific binding was estimated in the presence of 1 AM nifedipine. After incubation, membranes collected on Whatman GF/F filters were washed twice with 10 ml of icecold 0.9% NaCl.
[3H]-ouabain binding was measured in a 'Mg-Pi' medium (370C, 60 min) as previously described (Noel & Godfraind, 1984) . Non-specific binding was estimated in the presence of 1 mM ouabain. Membranes were collected on GF/F filters and washed twice with 10 ml of chilled 10 mM (KD) and BmaX were calculated by linear regression. In competitive experiments, displacement curves were analysed by a sigmoid curve fitting programme (Munson & Rodbard, 1980 ). An iterative technique gave estimate of IC50 (concentration of displacer inhibiting 50% of specific binding) and the Ki value was calculated according to Cheng & Prusoff (1973) .
Results
The specific binding of [3H]-(+)-isradipine to tissue homogenates was saturable in the concentration range of 25-250pM. As shown in Table 1 Figure 1 ). Slopes of Hill plots (not shown) were close to 1. The Ki value derived from the concentration for half-maximal inhibition (IC50) according to Cheng & Prusoff (1973) suggest that this drug allosterically interacts with the dihydropyridine recognition site, as previously found for other drugs (Murphy et al., 1983; Glossmann et al., 1985) . However, in dissociation experiments (Figure 2) (Schoemaker & Langer, 1985) . To fraction from rat brain, because we met with difficulties when using membranes from intestinal muscle (data not shown). As shown in Figure 6 , (+)-cis-diltiazem inhibited [3H]-diltiazem binding with an IC50 of 128 nm at 370C and 42 nm at 30'C (Hill coefficient 0.6-0.7), in agreement with previous findings (Schoemaker & Langer, 1985 (Figure 3 ). It is well-known that ouabain binding sites are exposed on the outside of the plasma membrane and are, therefore, inaccessible to ouabain in sealed inside-out vesicles. The percentage of sealed inside-out vesicles as determined in this manner (18.8%), is in good agreement with the proportion of the [3H]-(+)-isradipine binding sites that appear to be inaccessible to pinaverium bromide (20%). Thus, our findings support the view that the site of the calcium channel that interacts with dihydropyridines lies near the external surface of the plasma membrane, as previously proposed by Kass et al. (1989) from their study on the effect of external pH on the interaction of amlodipine (pKa 8.6) with the calcium channel, and more recently, from the finding that a permanently charged (quaternary ammonium) dihydropyridine derivative inhibits L-channel current when applied extra-, but not intracellularly (Kass et al., 1991) . However, a recent study that used photoaffinity labelling to locate the dihydropyridine binding site in the Ca channel al subunit of skeletal muscle claimed that this site has a cytosolic localization (Regulla et al., 1991 ).
An additional conclusion that can be drawn from our results is that collagenase might be deleterious for the voltagedependent Ca2+ channels. Indeed, the KD of [3H]-(+)-isradipine and the Ki of pinaverium bromide were both appreciably increased in cells obtained by collagenase digestion and in tissue homogenates treated with collagenase. These observations support the view, expressed by Rusch & Hermsmeyer (1988) , that 'dissociating methods for cell dispersion cannot be regarded as innocent of influencing calcium channel viability'.
